This activity is sponsored by The Center for Health Care Education, LLC (CHCE) –Maximum of 1.75 category 1 credits toward the AMA Physician’s Recognition Award This activity is supported by an unrestricted educational grant from Pfizer Inc. CME Sponsor and Commercial Supporter Information
CME Faculty Disclosure Policy It is the policy of the CME sponsor to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities Each speaker has disclosed any real or apparent conflict of interest related to the content of his/her presentation Disclosure information is provided in each of the presenter’s presentations.
Overall Program Learning Objectives Describe the challenges emergency department physicians face when treating the agitated patient Compare and contrast the various treatment options for acute agitation including conventional and new atypical antipsychotics Demonstrate the benefits of treatment choices for the emergency physician, the treatment team, and the patient At the conclusion of this activity, participants should be able to: